加载中
NASDAQHealthcareMedical - Instruments & Supplies
最新数据
US$37.77
+US$0.05 · +0.13%
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
前收盘价
US$37.77
+US$0.05 · +0.13%
盘前
US$38.77
+US$1.00 · +2.65%
10月13日 6:13 ET
盘中时间采用ET。市场数据可能有所延迟。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日内区间
当前US$37.77
52周区间
当前US$37.77
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
47
合理估值
情绪
54
多空交织
风险
55
风险偏高
动量
39
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日内区间
当前US$37.77
52周区间
当前US$37.77
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 5.94亿 USD | 5.73亿 USD | 6.65亿 USD | 5.55亿 USD | 5.14亿 USD |
| 销货成本 | 3.24亿 USD | 3.19亿 USD | 4.32亿 USD | 3.25亿 USD | 2.99亿 USD |
| 毛利 | 2.7亿 USD | 2.55亿 USD | 2.33亿 USD | 2.31亿 USD | 2.15亿 USD |
| 研究与开发 | 3039万 USD | 3152.4万 USD | 3395.6万 USD | 2754.2万 USD | 2241.2万 USD |
| 销售、一般及管理费用 | 2.51亿 USD | 2.53亿 USD | 2.81亿 USD | 2.27亿 USD | 1.89亿 USD |
| 营业费用 | 2.82亿 USD | 2.85亿 USD | 3.15亿 USD | 2.55亿 USD | 2.11亿 USD |
| 利息收入 | 1877.9万 USD | 3317.7万 USD | 4373.5万 USD | 2028.6万 USD | 63.2万 USD |
| 利息支出 | — | — | — | 458.9万 USD | 203.7万 USD |
| 折旧和摊销 | 6120.9万 USD | 9074.4万 USD | 8558.4万 USD | 5370.2万 USD | 5687.2万 USD |
| 营业利润 | −1126.8万 USD | −2998.1万 USD | −8219.8万 USD | −2402.3万 USD | 359.6万 USD |
| 净利润 | −5576.3万 USD | −1.65亿 USD | −1425.7万 USD | −4.29亿 USD | 1.11亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$43.00
上涨空间 13.85%年度分割调整后的每股现金分配。
US$0.40
2021年（完整年度）0.0% 自从 2017
US$0.40
2,017
US$0.40
2,018
US$0.40
2,019
US$0.40
2,020
US$0.40
2,021
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2021年12月2日 | US$0.10Quarterly | 2021年12月3日 | 2021年12月23日 |
股息 | 2021年9月2日 | US$0.10Quarterly | 2021年9月3日 | 2021年9月24日 |
股息 | 2021年6月3日 | US$0.10Quarterly | 2021年6月4日 | 2021年6月25日 |
股息 | 2021年3月4日 | US$0.10Quarterly | 2021年3月5日 | 2021年3月26日 |
股息 | 2020年12月3日 | US$0.10Quarterly | 2020年12月4日 | 2020年12月17日 |
股息 | 2020年9月3日 | US$0.10Quarterly | 2020年9月4日 | 2020年9月25日 |
除息 2021年12月2日
US$0.10
Quarterly
2021年12月3日登记 · 支付日 2021年12月23日
除息 2021年9月2日
US$0.10
Quarterly
2021年9月3日登记 · 支付日 2021年9月24日
除息 2021年6月3日
US$0.10
Quarterly
2021年6月4日登记 · 支付日 2021年6月25日
除息 2021年3月4日
US$0.10
Quarterly
2021年3月5日登记 · 支付日 2021年3月26日
除息 2020年12月3日
US$0.10
Quarterly
2020年12月4日登记 · 支付日 2020年12月17日
除息 2020年9月3日
US$0.10
Quarterly
2020年9月4日登记 · 支付日 2020年9月25日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4315.42万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM4151.84万0.05%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB3114.85万0.02%1853亿 USD0.03%US$288.16-0.46%
Vanguard Morningstar Small-Cap Value ETFVBR1979.14万0.03%682亿 USD0.05%US$234.71+0.12%
Vanguard Extended Market ETFVXF1554.29万0.02%954亿 USD0.05%US$233.52-0.63%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1464.28万0.05%268.33亿 USD0.33%US$37.98+0.08%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1364.36万0.09%157.12亿 USD0.03%US$53.42-0.06%
Schwab U.S. Small-Cap ETFSCHA789.01万0.04%217.13亿 USD0.03%US$32.66-0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFU.S. Small Cap Value Portfolio ETF Class SharesDFSVState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMSchwab U.S. Small-Cap ETFSCHAAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
